The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.
Recs
evanmacdonald
(79.83)
Submitted: 18/03/2013 17:02:08 :
Start Price:
$46.01
AZN.US Score:
+6.66
Restructuring will cut fat while they restock their drug pipeline, and should eventually allow them to continue raising their dividend.
Recs
IlanBigfoot
(72.56)
Submitted: 30/12/2012 22:45:05 :
Start Price:
$44.47
AZN.US Score:
-1.35
High yield strategy: TMFHighYield says to look for "high dividend payers from the S&P 500 from diverse sectors, relatively low debt, and a history of increasing dividend payments." This is my Health Care pick.
$46.88
Recs
mlkf
(< 20)
Submitted: 20/10/2012 10:28:30 :
Start Price:
$44.88
AZN.US Score:
+0.61
Product offering
Recs
Recs
Reddragyn
(67.51)
Submitted: 21/07/2012 05:57:46 :
Start Price:
$42.70
AZN.US Score:
-1.07
SP Low PE
Recs
rainmaker59
(52.75)
Submitted: 17/07/2012 15:19:51 :
Start Price:
$43.27
AZN.US Score:
-0.89
Meets my metrics of low PE, high yield, eps, beta, roe and net profit. And 10 percent below 52-week high.
Recs
line70day
(24.56)
Submitted: 01/06/2012 13:06:35 :
Start Price:
$37.46
AZN.US Score:
+10.67
5star
good div
good cash flow
esp growth 24.00
new cancer treatment in the works
Recs
Marlonito9
(< 20)
Submitted: 30/05/2012 05:44:27 :
Start Price:
$40.20
AZN.US Score:
-7.26
It probably will because of many reasons. One is timeline. At the long run, this will outrun it's competitors in the market.
Recs
ihaveabaddober
(55.06)
Submitted: 23/05/2012 15:48:43 :
Start Price:
$38.26
AZN.US Score:
+10.80
DIVIDEND/ROE MONSTER
Recs
jwray01
(99.63)
Submitted: 09/05/2012 01:48:26 :
Start Price:
$40.27
AZN.US Score:
+6.85
Very low P/E.
Recs
SpartanMAC
(37.45)
Submitted: 07/05/2012 10:52:47 :
Start Price:
$41.00
AZN.US Score:
+6.09
Selling at a discount. I would like to see some new drugs come through to keep the high ROIC going...
Recs
outoffocus
(24.53)
Submitted: 27/04/2012 14:39:36 :
Start Price:
$40.77
AZN.US Score:
+9.98
low p/e high div yield
Recs
Buffettinvestor
(62.97)
Submitted: 03/04/2012 15:01:59 :
Start Price:
$41.92
AZN.US Score:
+6.84
Very cheap stock, with under 6 p/e, but still earning incredible returns on capital. Has been hit too hard among the pharmaceutical firms. Great contrarian play, with a great dividend Yield of over 6%.
Recs
Recs
Recs
ETMatyahoo
(49.50)
Submitted: 23/12/2011 17:43:07 :
Start Price:
$41.26
AZN.US Score:
-4.92
Note to self: "actually" in at 44.ish in this week - late Fool-tracking. Sad disclosure!
AZN's the maker of Seroquel and Mysoline, two really far out psychiatric neurological drugs. So I hear.
Recs
Recs
Chemdawg
(94.70)
Submitted: 08/10/2011 13:57:28 :
Start Price:
$41.99
AZN.US Score:
-16.56
buybacks...great yield.... 10% off 52 week low
Recs
jmt587
(99.89)
Submitted: 22/09/2011 14:10:02 :
Start Price:
$38.05
AZN.US Score:
-10.63
Long Term Outperform.
Recs
d0w0kelley
(< 20)
Submitted: 28/08/2011 00:27:40 :
Start Price:
$41.57
AZN.US Score:
-13.09
Large Cap stock trading above their 14-day SMA
For details about CAPS-UK, and the conditions you agree to be bound by, please see our Terms and Conditions.
This page brought to you by USEQ\WEB22.
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 124 : 1 2 3 4 5 6 7 Next »